Amgen tosses back unwanted bispecific to Xencor as KRAS data on track for 2020 readout

Amgen tosses back unwanted bispecific to Xencor as KRAS data on track for 2020 readout

Submitted by admin on July 29, 2020 - 12:04pm
Source: 
Fierce Biotech
News Tags: 
Amgen
bispecific antibodies
Xencor
Headline: 
Amgen tosses back unwanted bispecific to Xencor as KRAS data on track for 2020 readout
snippet: 

Amgen has culled a bispecific drug it picked up in a $1.7 billion biobucks deal with Xencor.

Do Not Allow Advertisers to Use My Personal information